Related Experiment Video

Updated: Aug 15, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

[Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy]

H P Schultheiss1, M Noutsias, U Kühl

  • 1Medizinische Klinik II, Kardiologie und Pneumologie, Charité Universitätsmedizin Berlin. heinz-peter.schultheiss@charite.de

Der Internist
|October 18, 2005
PubMed

Insights

Cardiomyopathies, common causes of heart failure, are classified by WHO. Diagnosis involves various methods, with biopsies confirming specific types like inflammatory cardiomyopathy.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Genetics

Context:

  • Cardiomyopathies are significant causes of heart failure and sudden cardiac death.
  • The World Health Organization (WHO) classifies cardiomyopathies into "specific" and "idiopathic" categories based on pathophysiological characteristics.

Purpose:

  • To outline the diagnostic approaches for cardiomyopathies.
  • To highlight the role of advanced investigations in verifying specific cardiomyopathy types.
  • To discuss current treatment and prevention strategies.

Summary:

  • Diagnostic evaluation encompasses a wide range of non-invasive and invasive cardiological techniques.
  • Endomyocardial biopsies, analyzed through immunohistological and molecular biological methods, are crucial for confirming conditions like inflammatory cardiomyopathy, often virus-induced.
  • Genetic/familial dilated cardiomyopathy is linked to identified gene mutations, necessitating screening of first-degree relatives.

Impact:

  • Immunomodulatory treatments show potential to halt the progression of inflammatory cardiomyopathy.
  • Early screening of relatives can facilitate early detection of genetic cardiomyopathies.
  • Implantable defibrillators are increasingly favored over pharmacological treatments for primary prevention of sudden cardiac death.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...